<DOC>
	<DOCNO>NCT00181571</DOCNO>
	<brief_summary>This double-blind , placebo-controlled study use daily dos 1.3 mg/kg/day Concerta treatment adult DSM-IV diagnosis attention deficit hyperactivity disorder ( ADHD ) ( childhood onset ) . We hypothesize ADHD symptomatology adult DSM-IV ADHD responsive Concerta treatment Concerta-associated response ADHD symptomatology adult sustain time .</brief_summary>
	<brief_title>A Double-Blind Comparison Concerta Placebo Adults With Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description>Concerta specially develop replace three-times-a-day IR methylphenidate , make ideal option patient ADHD . Moreover , once-a-day administration Concerta secure steady delivery methylphenidate across day , minimize well-known risk peak valley IR methylphenidate , could offer added advantage pharmacokinetic advantage once-a-day administration . Despite putative advantage , whether new delivery system lead result document immediate-response methylphenidate treatment adult ADHD require empirical corroboration . To end conduct randomize controlled clinical trial evaluate short- medium-term safety efficacy Concerta treatment adult ADHD without co-morbid psychiatric disorder . We also wish examine role genetics predict ADHD treatment response Concerta . There grow literature support role genetic factor treatment response youth ADHD , seek explore relationship adult . The propose study include use 34-week design document response rate , assessment impact Concerta functional capacity ( quality life , psychosocial function ) cognition , careful assessment safety tolerability .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Male female outpatient older 18 young 55 year age . 2 . Subjects diagnosis attention deficit hyperactivity disorder ( ADHD ) , DSMIV , manifest clinical evaluation confirm structured interview . 3 . ADHD Symptom Checklist score &gt; 24 . 4 . Patients past history depression , bipolar disorder , anxiety disorder ( include OCD ) without current disorder &gt; 3 month ascertain structured diagnostic interview clinical exam . 5 . Subjects treat anxiety disorder depression stable medication regimen least three month , disorderspecific CGISeverity score â‰¤ 3 ( mildly ill ) score HamiltonDepression HamiltonAnxiety rating scale 15 ( mild range ) . 6 . Subjects past history tic tic free &gt; 1 year . 7 . Subjects past history substance use disorder substance free &gt; 6 month . 8 . Subjects receive nonMAOI antidepressant ( e.g. , SSRI 's , bupropion , venlafaxine ) benzodiazepines stable regimen &gt; 3 month condition list . 1 . Any clinically unstable psychiatric condition include follow : acute psychosis , acute panic , acute OCD , acute mania , acute suicidality , bipolar disorder , acute substance use disorder ( alcohol drug , sociopathy , criminality , delinquency . 2 . Any metabolic , neurological , hepatic , renal , cardiovascular , hematological , opthalmic , endocrine disease . 3 . Clinically significant abnormal baseline laboratory value include follow : 1 . Values &gt; 20 % upper range laboratory standard basic metabolic screen . 2 . Exclusionary blood pressure &gt; 140 ( systolic ) 90 ( diastolic ) . 3 . Exclusionary ECG parameter : QTC &gt; 460 msec , QRS &gt; 120 msec , PR &gt; 200 msec . Subjects ECG evidence ischemia arrhythmia review independent cardiologist . 4 . Mental retardation ( IQ &lt; 75 ) . 5 . Organic brain disorder . 6 . Seizures tic last year . 7 . Pregnant nursing female . 8 . Subjects current adequate treatment ADHD history previous adequate trial Concerta . 9 . NonEnglish speaking subject allow study follow reason : 1. assessment instrument unavailable adequately standardized language ; 2. clinical trial facility locate Cambridge MGH main campus ; thus translator unavailable ; 3. even translation service available , assessment English language conduct Englishspeaking clinician raters Englishspeaking subject already extremely timeconsuming , last many hour , make unfeasible , unrealistic , dubious clinical validity conduct translator nonEnglishspeaking subject ; 4. psychiatric questionnaire evaluation tax , add complexity translator potential make patient experience even exhaust</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Adults</keyword>
	<keyword>Concerta</keyword>
	<keyword>Double-Blind</keyword>
</DOC>